BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30381496)

  • 1. Evaluation of glycemic status during the days of hemodialysis using dialysis solutions with and without glucose.
    Padmanabhan A; Velayudham B; Vijaykumar N; Allauddin S
    Saudi J Kidney Dis Transpl; 2018; 29(5):1021-1027. PubMed ID: 30381496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-induced hypoglycemia in diabetic patients.
    Jackson MA; Holland MR; Nicholas J; Lodwick R; Forster D; Macdonald IA
    Clin Nephrol; 2000 Jul; 54(1):30-4. PubMed ID: 10939754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
    Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
    J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
    Abe M; Kaizu K; Matsumoto K
    Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.
    Jung HS; Kim HI; Kim MJ; Yoon JW; Ahn HY; Cho YM; Oh KH; Joo KW; Lee JG; Kim SY; Park KS
    Diabetes Technol Ther; 2010 Oct; 12(10):801-7. PubMed ID: 20809681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
    Krahn RE; Tulowitzki R; Gudleski GD; Murray B; Rajagopalan B; Su W; Muscarella M; Lambert J; Curtis AB; Panesar M
    Am J Nephrol; 2019; 49(1):74-80. PubMed ID: 30602157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hypoglycemia caused by hemodialysis.
    Jackson MA; Holland MR; Nicholas J; Talbot M; Spencer H; Lodwick R; Fuhrmann C; Forster D; Macdonald IA
    Clin Nephrol; 1999 Apr; 51(4):242-7. PubMed ID: 10230557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of hypoglycemia during hemodialysis in diabetic patients is related to lower pre-dialysis glycemia.
    Burmeister JE; Miltersteiner Dda R; Burmeister BO; Campos JF
    Arch Endocrinol Metab; 2015 Apr; 59(2):137-40. PubMed ID: 25993676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
    Hayashi A; Shimizu N; Suzuki A; Matoba K; Momozono A; Masaki T; Ogawa A; Moriguchi I; Takano K; Kobayashi N; Shichiri M
    Diabetes Care; 2021 Jul; 44(7):1647-1656. PubMed ID: 34045240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
    Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
    J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
    J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Hemodialysis and Peritoneal Dialysis on Glycometabolism in Patients with End-Stage Diabetic Nephropathy.
    Chen XX; Duan Y; Zhou Y
    Blood Purif; 2021; 50(4-5):506-512. PubMed ID: 33302273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis.
    Park S; Paredes W; Custodio M; Goel N; Sapkota D; Bandla A; Lynn RI; Reddy SM; Hostetter TH; Abramowitz MK
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1418-F1429. PubMed ID: 32308019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in blood glucose and lactate concentrations with hemodialysis.
    Watha K; Davenport A; Tangvoraphonkchai K
    Artif Organs; 2022 Jan; 46(1):138-145. PubMed ID: 34695248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate.
    Ramsauer B; Engels GE; Graaff R; Sikole A; Arsov S; Stegmayr B
    BMC Nephrol; 2017 Jan; 18(1):5. PubMed ID: 28056864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.
    de Paula FM; Peixoto AJ; Pinto LV; Dorigo D; Patricio PJ; Santos SF
    Kidney Int; 2004 Sep; 66(3):1232-8. PubMed ID: 15327422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac arrhythmia during early-week and mid-week dialysis in hemodialysis patients.
    Vareesangthip K; Yincharoen P; Winijkul A; Chanchairujira T
    Ther Apher Dial; 2021 Dec; 25(6):890-898. PubMed ID: 33470546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.